JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies.
- DOI
- 10.3389/fcell.2022.942053
- Published
- 2022
- Container
- Frontiers in cell and developmental biology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fcell.2022.942053,
title = {JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies.},
author = {Downes CE and McClure BJ and McDougal DP and Heatley SL and Bruning JB and Thomas D and Yeung DT and White DL},
year = {2022},
journal = {Frontiers in cell and developmental biology},
doi = {10.3389/fcell.2022.942053},
url = {https://doi.org/10.3389/fcell.2022.942053}
}RIS
TY - JOUR TI - JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies. AU - Downes CE AU - McClure BJ AU - McDougal DP AU - Heatley SL AU - Bruning JB AU - Thomas D AU - Yeung DT AU - White DL PY - 2022 JO - Frontiers in cell and developmental biology DO - 10.3389/fcell.2022.942053 UR - https://doi.org/10.3389/fcell.2022.942053 ER -
APA
CE, D., BJ, M., DP, M., SL, H., JB, B., D, T., DT, Y., & DL, W. (2022). JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies.. Frontiers in cell and developmental biology. https://doi.org/10.3389/fcell.2022.942053
Source records
- pubmed · retrieved 2026-11-10T08:09:05.634Z